🇺🇸 FDA
Patent

US 8003764

Folliculin-specific antibodies and methods of detection

granted A61KA61K38/00A61P

Quick answer

US patent 8003764 (Folliculin-specific antibodies and methods of detection) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K38/00, A61P, A61P17/00